Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Core Mechanism and Indications of TepotinibTepotinib is a precision targeted therapy that works by specifically inhibiting the MET protein, which drives cancer growth. By blocking ···【more】
Article source：Captain MedicineRelease date：2026-06-15Recommended：199
Low Blood Sugar Risk and Drug Interactions with OrforglipronPatients using Orforglipron need to pay special attention to the risk of hypoglycemia (low blood sugar), especially when···【more】
Article source：Captain MedicineRelease date：2026-06-12Recommended：245
Mechanism of Action of OrforglipronThe active ingredient in Orforglipron is orforglipron, which belongs to a class of medications known as GLP-1 receptor agonists. GLP-1 is a natur···【more】
Article source：Captain MedicineRelease date：2026-06-12Recommended：269
Dose Escalation Regimen and Storage Conditions for OrforglipronWhen using Orforglipron, physicians typically adopt a gradual dose escalation regimen to allow your body adequate tim···【more】
Article source：Captain MedicineRelease date：2026-06-11Recommended：242
Indicated Population and Basic Positioning of OrforglipronOrforglipron is a prescription medication clearly indicated for adults with obesity, or for adults who are overweight but ···【more】
Article source：Captain MedicineRelease date：2026-06-11Recommended：233
Managing Skin Side Effects of MirdametinibOne of the most common side effects of Mirdametinib treatment is rash, which may appear as flat rash, raised red bumps, acne-like pimples,···【more】
Article source：Captain MedicineRelease date：2026-06-10Recommended：208
Mirdametinib: Most Common Side Effects in ChildrenIn pediatric and adolescent patients (ages 2 to 17), the most common side effects of mirdametinib differ somewhat from those in ad···【more】
Article source：Captain MedicineRelease date：2026-06-10Recommended：229
Most common side effects of mirdametinib in adultsAccording to clinical trial data for mirdametinib, the most common adverse reactions in adult patients mainly include five aspects···【more】
Article source：Captain MedicineRelease date：2026-06-09Recommended：199
What is Mirdametinib?Mirdametinib is a prescription medicine specifically used to treat adults and pediatric patients aged 2 years and older who have neurofibromatosis type 1 (NF1)···【more】
Article source：Captain MedicineRelease date：2026-06-09Recommended：206
Effect of Other Drugs on RepotrectinibAvoid concomitant use of repotrectinib with P-glycoprotein inhibitors, strong or moderate CYP3A inducers, and strong or moderate CYP3A inhibit···【more】
Article source：Captain MedicineRelease date：2026-06-05Recommended：285
Common Adverse Reactions of RepotrectinibThe safety of Repotrectinib was evaluated in 426 patients in the TRIDENT-1 study. Overall, most adverse reactions were Grade 1 or 2, but so···【more】
Article source：Captain MedicineRelease date：2026-06-05Recommended：272
Repotrectinib Use in Special PopulationsBased on literature reports of human congenital mutations leading to altered tropomyosin receptor tyrosine kinase signaling, animal study re···【more】
Article source：Captain MedicineRelease date：2026-06-04Recommended：246
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended：[list:visits]2025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：[list:visits]2024-09-07
Lucius Pharmaceuticals Version of Vibegron Now Available1.Basic Drug InformationVibegron (generic na···【more】
Recommended：[list:visits]2026-06-08
In recent years, leveraging the World Trade Organization (WTO) patent waiver for least-developed cou···【more】
Recommended：[list:visits]2026-05-08
How Can Chinese Patients Access Generic Drugs from Laos?In recent years, generic drugs from Laos hav···【more】
Recommended：[list:visits]2026-04-08
Lucius Pharmaceuticals version of Ibrutinib is now availableIn a randomized controlled trial of 269 ···【more】
Recommended：[list:visits]2026-03-08
Leveraging the WTO patent waiver for least-developed countries (extended to 2033), Laos has seen rap···【more】
Recommended：[list:visits]2026-31-07
Alectinib Has Been Launched in LaosAlectinib is an oral targeted therapeutic drug belonging to the c···【more】
Recommended：[list:visits]2026-30-07
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Name: Lucius
Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643
